No significant difference between ceftriaxone and cefotaxime in the emergence of antibiotic resistance in the gut microbiota of hospitalized patients: A pilot study.
Pilmis B, Jiang O, Mizrahi A, Nguyen Van JC, Lourtet-Hascoët J, Voisin O, Le Lorc'h E, Hubert S, Ménage E, Azria P, Borie MF, Mahé A, Mourad JJ, Trabattoni E, Ganansia O, Zahar JR, Le Monnier A.
Pilmis B, et al.
Int J Infect Dis. 2021 Mar;104:617-623. doi: 10.1016/j.ijid.2021.01.025. Epub 2021 Jan 13.
Int J Infect Dis. 2021.
PMID: 33453395
Free article.
Clinical Trial.